Company Sedana Medical AB

Equities

SEDANA

SE0015988373

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 11:29:47 2024-04-26 am EDT			5-day change	1st Jan Change
20.65 ^SEK	+9.14%		+44.00%	-10.84%

Apr. 25	Transcript : Sedana Medical AB, Q1 2024 Earnings Call, Apr 25, 2024
Apr. 25	Sedana Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Business Summary

Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Companyâs main shareholders are board members, Linc AB and Magiola Consulting AB.

Number of employees: 79

Sales per Business

SEK in Million	2022	Weight	2023	Weight	Delta
Direct Sales Markets 92.4 %	108	87.8 %	142	92.4 %	+31.85%
Distribution Markets 7.6 %	15	12.2 %	12	7.6 %	-22.22%

Sales per region

SEK in Million	2022	Weight	2023	Weight	Delta
Germany 68.6 %	86	70.1 %	106	68.6 %	+22.67%
Other Direct Markets 23.3 %	21	17.4 %	36	23.3 %	+67.63%
Distributor Markets 7.6 %	15	12.2 %	12	7.6 %	-22.22%
Sweden 0.5 %	0	0.3 %	1	0.5 %	+104.89%

Managers

Managers	Title	Age	Since
Johannes Doll CEO	Chief Executive Officer	43	21-09-30
Johan Spetz DFI	Director of Finance/CFO	-	22-04-03
Peter Fröberg CTO	Chief Tech/Sci/R&D Officer	53	20-10-31
Peter Sackey CTO	Chief Tech/Sci/R&D Officer	53	18-01-07
Ron Farrell CTO	Chief Tech/Sci/R&D Officer	68	00-12-31
Ola Gunnar Magnusson BRD	Director/Board Member	76	04-12-31
Jessica Westfal IRO	Public Communications Contact	50	19-12-31
Stefan Krisch PRN	Corporate Officer/Principal	50	21-02-28
Sylvia Buddenbaum Eriksson HRO	Human Resources Officer	56	20-07-31
Karolina Vilval LAW	General Counsel	45	22-07-31

Members of the board

Members of the board	Title	Age	Since
Hilde Furberg BRD	Director/Board Member	65	21-12-31
Christoffer Rosenblad BRD	Director/Board Member	49	20-05-18
Claus Bjerre CHM	Chairman	53	21-05-09
Ola Gunnar Magnusson BRD	Director/Board Member	76	04-12-31
Eva Walde BRD	Director/Board Member	61	17-12-31

Share class

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	99,336,960	63,074,409 ( 63.50 %)	0	63.50 %

Shareholders

Name	Equities	%	Valuation
LINC AB 10.18 %	10,111,030	10.18 %	15 M kr
Anders Walldov 10.07 %	10,000,000	10.07 %	15 M kr
Swedbank Robur Fonder AB 9.180 %	9,119,013	9.180 %	14 M kr
E. Öhman J :or Fonder AB 6.832 %	6,787,053	6.832 %	10 M kr
Ola Gunnar Magnusson 4.341 %	4,312,098	4.341 %	6 M kr
Sten Gibeck 4.225 %	4,196,597	4.225 %	6 M kr
Highclere International Investors LLP 3.333 %	3,310,435	3.333 %	5 M kr
AMF Fonder AB 2.508 %	2,491,000	2.508 %	4 M kr
Joh. Berenberg, Gossler & Co. KG (Investment Management) 2.013 %	2,000,059	2.013 %	3 M kr
Tredje AP-fonden 1.748 %	1,735,989	1.748 %	3 M kr